Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - Commentary.
Corboy JR. Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - Commentary. Mult Scler. 2017 08; 23(9):1192-1193.